Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

NCT04537689 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Plaque Psoriasis

Interventions

BIOLOGICAL: Ixekizumab
DRUG: Methotrexate
DRUG: Cyclosporin A
DRUG: Acitretin

Sponsor

Singapore General Hospital

Collaborators

[object Object]